HERNİYASYON İLE PREZENTE BACİLLUS CALMETTE-GUERİN (BCG) AŞISIZ PEDİATRİK TÜBERKÜLOZ MENİNGOENSEFALİT OLGUSU

Öz

Tüberküloz günümüzde halen belli başlı ölüm sebeplerinden bir tanesidir. Yüksek aşılama oranları ile tüberküloz meningoensefalit vakaları belirgin azalmış olmakla birlikte, göç gibi sosyal problemler nedeniyle bu klinik tablonun halen görülebileceğine sunduğumuz bu olgu ile dikkat çekilmek istenmiştir. Tüberküloz menenjitin hızla tanısı ve tedavisinin önemi vurgulanmak istenmiştir. Özellikle mülteciler gibi düşük gelirli ve sağlık güvencesi olmayan gruplarda, aşıyla önlenebilir hastalıkların ve komplikasyonlarının akılda tutulması önemlidir.

Anahtar Kelimeler

• Aşı
• menenjit
• tüberküloz.

HERNIATION PRESENTED CASE OF PEDIATRIC TUBERCULOSIS MENINGOENSEPHALIT UNVACCINATED WITH BACILLUS CALMETTE-GUERIN (BCG)

Öz

Tuberculosis is still one of the main causes of death today. Although the cases of tuberculous meningoencephalitis have decreased significantly with high vaccination rates, it is necessary to draw attention to the fact that this clinical picture can still be seen due to social problems such as migration.It is desirable to emphasize the importance of rapid diagnosis and treatment of tuberculous meningitis.It is important to keep in mind the vaccine-preventable diseases and their complications, especially in low-income and non-health-assured groups such as refugees.

Anahtar Kelimeler

• Vaccine
• meningitis
• tuberculosis.

Kaynakça

1. 1. Isa F, Collins S, Lee MH, Decome D, Dorvil N, Joseph P, et al. Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis. EBioMedicine 2018;31:157-65.
2. 2. Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020 Jan;8(1):19.
3. 3. Barniol J, Niemann S, Louis VR, et al. Transmission dynamics of pulmonary tuberculosis between autochthonous and immigrant sub-populations. BMC Infect Dis 2009:9:197.
4. 4. Andronikou S, Smith B, Hatherhill M, Douis H, Wilmshurst J. Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol 2004 Nov;34(11):876-85.
5. 5. Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci 2010 Jun 15;293(1-2):12-7.
6. 6. Daniel BD, Grace GA, Natrajan M. Tuberculous meningitis in children: Clinical management & outcome. Indian J Med Res. 2019 Aug;150(2):117-130. doi: 10.4103/ijmr.IJMR_786_17. PMID: 31670267; PMCID: PMC6829784.
7. 7. Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 2014;6(2):152-8.
8. 8. Fletcher HA, Schrager L. TB vaccine development and the End TB Strategy: importance and current status. Trans R Soc Trop Med Hyg 2016 Apr;110(4):212-8.

9. 9. Hong CY, Wang F, Gui J, Liu XL. Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide. Zhonghua Yu Fang Yi Xue Za Zhi 2012 May;46(5):436-9.
10. 10. Stop TB Partnership Childhood TB Subgroup World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children. Int J Tuberc Lung Dis 2006 Oct;10(10):1091-7.
11. 11. Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet. 2005;366(9495):1443-51.
12. 12. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006;367:1173-80.
13. 13. T.C. Sağlık Bakanlığı Tüberküloz Tanı ve Tedavi Rehberi Akdağ R, editor2011.
14. 14. Floyd K, Global tuberculosis control - epidemiology, strategy, financing. WHO Report 2009 https://apps.who.int/iris/bitstream/handle/10665/44241/9789241598866_eng.pdf?sequence=1. Erişim tarihi:9.1.2022
15. 15. Nelson LJ, Wells CD. Çocukluk çağı tüberkülozu küresel epidemiyolojisi. Int J Tuberc Lung Dis 2004;8:636-47.
16. 16. Ortblad KF, Salomon JA, Bärnighausen T, Atun R. Stopping tuberculosis: a biosocial model for sustainable development. Lancet. 2015;386(10010):2354-62.
17. 17. Parthasarathy A, Hitt S. BCG Vaccination: Is there light at end of the tunnel ?. Journal of Pediatric Sciences 2010;5:e48.
18. 18. Kenyon TA, Driver C, Haas E, Valway SE, Moser KS, Onorato IM. Immigration and tuberculosis among children on the United States-Mexico border, County of San Diego, California. Pediatrics 1999;104(1):e8.
19. 19. Diel R, Schneider S, Meywald-Walter K, Ruf CM, Rüsch-Gerdes S, Niemann S. Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol 2002;40(2):532-9.
20. 20. Kentikelenis A, Karanikolos M, Williams G, Mladovsky P, King L, Pharris A, et al. How do economic crises affect migrants' risk of infectious disease? A systematic-narrative review. Eur J Public Health. 2015 Aug 28. pii: ckv151.
21. 21. Nakken CS, Skovdal M, Nellums LB, Friedland JS, Hargreaves S, Norredam M. Vaccination status and needs of asylum-seeking children in Denmark: a retrospective data analysis. Public Health 2018;158:110-16.